Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
These strategies can form a treatment plan for neurodegenerative diseases and brain injuries, and future work should focus on optimizing delivery and translation for better results
GLP-1s and other FDA-approved drugs have objective markers to establish whether they actually work, such as HbA1c levels for blood sugar and measurable weight loss
Long-term differential effects of gastric bypass and sleeve gastrectomy on bone mineral density
Central GLP-1 receptor activation improves cholesterol metabolism partially independent of its effect on food intake
Wang D-X, Yang Y, Huang X-S et al (2021) Pramipexole attenuates neuronal injury in Parkinsons disease by targeting miR-96 to activate BNIP3-mediated mitophagy
